$AIFF Balance Sheet | Understand Stock

$AIFF

$1.00 +$0.06 (6.33%) Close

$AIFF Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets (Current Period Unaudited)

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Current assets
Other current assets
Cash and cash equivalents
Accounts and other receivables, net
Prepaid expenses
Inventory
Total current assets
Non current assets
Prepaid expenses
Equipment, net
Contingent payments
Equity investment
Other assets
Assets held for sale
Intangible assets, net
Goodwill
Contract assets - non-current
Right-of-use operating lease asset
Total non current assets
TOTAL ASSETS

Current liabilities
Trade payables
Nonrelated Party
Total trade payables
Revolving line of credit
Premium financing note payable
Accrued payroll and related liabilities
Commissions payable
Income taxes payable
Other accrued liabilities
Accrued liabilities
Related Party
Total accrued liabilities
Contract with Customer, Liability, Current
Operating lease liabilities - current
Interest payable
Deferred acquisition consideration
Convertible promissory note, net of unamortized discount
Deemed dividend liability
Contingent consideration payable
Derivative liability
Total current liabilities
Note payable - non-current
Operating lease liabilities - non-current
Deferred tax liabilities, net
Other liabilities
Contingent acquisition consideration
Deferred acquisition consideration - non-current

Non current liabilities
Deferred revenue
TOTAL LIABILITIES
SHAREHOLDERS’ EQUITY
Preferred shares, $0.0001 par value: 1,000,000 shares authorized; nil issued and outstanding at June 30, 2026 and December 31, 2025
Common shares, $0.0001 par value: 5,000,000,000 shares authorized; 15,683,601 and 13,964,367 issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated deficit
Treasury stock, 1,673,051 and 1,642,616 shares at cost, as of December 31, 2022 and December 31, 2021, respectively
Treasury stock, 55,768 shares at cost, as of June 30, 2024 and December 31, 2023
TOTAL SHAREHOLDERS’ EQUITY
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

Comments